Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
77M
-
Number of holders
-
62
-
Total 13F shares, excl. options
-
11.9M
-
Shares change
-
+3.94M
-
Total reported value, excl. options
-
$106M
-
Value change
-
+$35.2M
-
Number of buys
-
53
-
Number of sells
-
-7
-
Price
-
$8.94
Significant Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q4 2016
63 filings reported holding CLSD - Clearside Biomedical, Inc. - Common Stock, $0.001 par value as of Q4 2016.
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) has 62 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.9M shares
of 77M outstanding shares and own 15.42% of the company stock.
Largest 10 shareholders include Cormorant Asset Management, LLC (2.33M shares), WELLINGTON MANAGEMENT GROUP LLP (1.64M shares), FMR LLC (1.03M shares), Rock Springs Capital Management LP (935K shares), PERCEPTIVE ADVISORS LLC (712K shares), Hillhouse Capital Management, Ltd. (600K shares), VANGUARD GROUP INC (585K shares), BlackRock Fund Advisors (551K shares), MARSHALL WACE, LLP (450K shares), and SPHERA FUNDS MANAGEMENT LTD. (300K shares).
This table shows the top 62 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.